Bridgebio Oncology Therapeutics Inc (BBOT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | BBOT | GYRE | LXRX | ||
| Company | Bridgebio Oncology Therapeutics Inc | Gyre Therapeutics Inc | Lexicon Pharmaceutcl | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 9.25 | 7.98 | 1.7000 | ||
| High | 9.28 | 8.01 | 1.7900 | ||
| Low | 8.80 | 7.55 | 1.6600 | ||
| Latest | 9.09 | 7.55 | 1.6900 | ||
| Change | -0.04 | -0.25 | -0.0300 | ||
| % Change | -0.44% | -3.20% | -1.74% | ||
| Volume | 191,800 | 138,300 | 2,245,500 | ||
| 20-Day Average Volume | 251,770 | 121,440 | 2,581,210 | ||
| Previous Close | 9.13 | 7.80 | 1.7200 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | No | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 10.14 | 8.18 | 1.5510 | ||
| 20-Day Raw Stochastic | 9.90% | 4.80% | 80.39% | ||
| 20-Day Relative Strength | 37.91 | 45.37 | 60.68 | ||
| Weighted Alpha | -24.52 | -23.25 | +257.11 | ||
| Today's Opinion | 72% Sell | 8% Buy | 100% Buy | ||
| Previous Opinion | 72% Sell | 32% Buy | 100% Buy | ||
| Last Month's Opinion | 40% Buy | 8% Buy | 64% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -12.76% since 03/06/26 | -2.01% since 03/06/26 | -1.17% since 03/06/26 | ||
| Low | 8.80 on 03/13/26 | 7.47 on 03/12/26 | 1.6100 on 03/11/26 | ||
| High | 10.78 on 03/09/26 | 8.51 on 03/10/26 | 1.7900 on 03/13/26 | ||
| 1-Month | |||||
| %Chg | -19.20% since 02/13/26 | -5.80% since 02/13/26 | +29.01% since 02/13/26 | ||
| Low | 8.80 on 03/13/26 | 7.47 on 03/12/26 | 1.2900 on 02/17/26 | ||
| High | 11.45 on 02/17/26 | 9.14 on 03/05/26 | 1.7900 on 03/13/26 | ||
| 3-Month | |||||
| %Chg | -27.80% since 12/12/25 | -1.76% since 12/12/25 | +30.00% since 12/12/25 | ||
| Low | 8.80 on 03/13/26 | 6.76 on 01/02/26 | 1.1000 on 01/30/26 | ||
| High | 14.60 on 01/09/26 | 9.14 on 03/05/26 | 1.8300 on 01/22/26 | ||
| 6-Month | |||||
| %Chg | -12.51% since 09/12/25 | -3.51% since 09/12/25 | +46.96% since 09/12/25 | ||
| Low | 8.80 on 03/13/26 | 6.76 on 01/02/26 | 1.0600 on 09/17/25 | ||
| High | 14.87 on 12/08/25 | 9.42 on 10/16/25 | 1.8300 on 01/22/26 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 727,500 | 727,796 | 716,021 | ||
| Shares Outstanding, K | 80,033 | 96,333 | 423,681 | ||
| Annual Sales | 0 | 105,760,000 | 49,800,000 | ||
| Annual Net Income | -134,040,000 | 12,090,000 | -50,340,000 | ||
| Last Quarter Sales | 0 | 30,560,000 | 5,490,000 | ||
| Last Quarter Net Income | -38,800,000 | 3,610,000 | -15,530,000 | ||
| 60-Month Beta | 0.28 | 1.97 | 0.94 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -1.03 on 11/12/25 | 0.06 on 11/07/25 | -0.04 on 11/06/25 | ||
| Latest Earnings Date | 06/04/26 | 05/08/26 | 05/12/26 | ||
| Most Recent Dividend | N/A | 0.569 on 08/20/15 | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 68.68 | 0.00 | ||